tiprankstipranks
Trending News
More News >
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF

Compare Santhera Pharmaceuticals Holding (SPHDF) vs. Competitors

Compare
38 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
$16.78
$231.74M
-2.75
72.82%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.56
CHF141.92M
-2.20
-20.69%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF57.60
CHF695.61M
9.63
41.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.50
CHF929.20M
-5.24
404.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF18.86
CHF395.49M
15.75
93.44%
2 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.40
CHF121.12M
3.97
-2.73%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPHDF
Santhera Pharmaceuticals Holding
16.28
6.86
72.82%
CH:MOLN
Molecular Partners AG
3.57
-0.90
-20.07%
CH:BSLN
Basilea Pharmaceutica
57.60
16.90
41.52%
CH:IDIA
Idorsia Ltd
3.51
2.80
400.71%
CH:NWRN
Newron Pharmaceuticals SpA
18.86
8.76
86.73%
CH:XLS
Xlife Sciences Ltd.
21.40
0.20
0.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts